Analyst Group Comment on STENOCARE ASTRUM 10-10 Oil Being Approved for Reimbursement in Germany

On April 4th, STENOCARE announced that the innovative ASTRUM 10-10 has obtained for approval for reimbursement in Germany through major health insurance providers. Starting in April 2025, approximately 14 million insured individuals will be eligible for 100% reimbursement when treated with ASTRUM 10-10.

Länk till analysen i sin helhet: https://analystgroup.se/kommentarer/comment-on-stenocare-astrum-10-10-oil-being-approved-for-reimbursement-in-germany/